Deanna L. Kirkpatrick
Ms. Kirkpatrick is a partner in Davis Polk’s Corporate Department and serves as Finance Partner as part of the firm's four-member senior leadership team. As Finance Partner, she is responsible for overseeing Davis Polk's finances. She is described by Chambers as "a real star," according to market sources and Chambers reports that clients comment that "she has a really good way with clients." Ms. Kirkpatrick was named a New York Law Journal "Distinguished Leader" in 2017, a Law360 "Capital Markets MVP" in 2016 and "Best in Capital Markets" by Euromoney LMG Americas Women in Business Law Awards in 2013.
As a senior member of the firm’s Capital Markets Group, her practice includes public equity, equity-linked debt and other securities offerings. She has regularly worked for both issuers and underwriters in connection with capital markets transactions. Ms. Kirkpatrick has worked on offerings for issuers over a broad spectrum of industries, including healthcare, retail, financial institutions, utilities, oil and gas, media and special-purpose acquisition companies.
Ms. Kirkpatrick has advised on numerous biotech and life sciences IPOs for the following companies: ADC Therapeutics, Ayala Pharmaceuticals, Beam Therapeutics, Progyny, Innate Pharma S.A., BioNTech SE, Stoke Therapeutics, Orchard Therapeutics plc, Aptinyx Inc., Magenta Therapeutics, Inc., Solid Biosciences Inc., InflaRx N.V., Kala Pharmaceuticals, Inc., Dova Pharmaceuticals, Inc., Jounce Therapeutics, Inc., Patheon N.V., Cynapsus Therapeutics Inc. and Oxford Immunotec. Other equity offerings include BioXcel and Millendo Therapeutics.
Ms. Kirkpatrick has also participated in securities offerings by Fortune 500 companies such as Abbott, DXC, Hess, L Brands, Lockheed Martin, VF Corporation and Walgreen's.
In addition, she has advised the underwriters on offerings by the Toronto Dominion Bank, Export Development Canada, the Government of Canada and various Canadian provinces.
She has also represented virtually all the major investment banks, including JPMorgan Chase, Citi, Goldman Sachs and Morgan Stanley as underwriters’ counsel in equity and debt offerings and regularly advises investment banking clients on securities law-related matters.
Ms. Kirkpatrick is consistently recognized for her work in the legal industry:
- New York Law Journal – "Distinguished Leader," 2017
- Law360 – "Capital Markets MVP," 2016
- Euromoney LMG Americas Women in Business Law Awards – “Best in Capital Markets,” 2013
- Chambers USA
- Finance Partner, Davis Polk & Wardwell, responsible for overseeing the firm’s finances as one of four members of the firm's senior leadership team
- Regularly participates as a speaker on various PLI panels
- Co-Author, “Role of the Law Firm” in NASDAQ’s Going Public: A Guide for North American Companies to Listing on the U.S. Securities Markets
- Senior Leadership Team, 2019-present
- Finance Partner, 2011-present
- Partner, 1997-present
- Associate, 1989-1997